AstraZeneca

EXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public Offerings
The Latest Barron's Picks And Pans: Meme Stocks, AstraZeneca, Citigroup And More
Barron's Latest Picks And Pans: DuPont, Stanley Black & Decker, Whirlpool And More
The Latest Barron's Picks And Pans: Meme Stocks, AstraZeneca, Citigroup And More
Barron's Latest Picks And Pans: DuPont, Stanley Black & Decker, Whirlpool And More
FDA, CDC Officials Discuss Johnson & Johnson Vaccine: A 'Pause Recommendation', Resolution Timeline And Advisory
Benzinga's Bulls And Bears Of The Week: Apple, Chevron, GM, GE, Peloton And More

AstraZeneca Recent News

Intel Helps Market Comeback As Shares Rise Following Announcement
Like spring weather, the stock market can be fickle. After yesterday’s blustery headwinds of coronavirus worry, this morning is pointing to a calmer day as stocks look to recover some ground.
Wednesday's Market Minute: Bulls Are Losing Their Touch
The powerful rotation trade that’s been raging since September finally hit a speed bump this past week thanks to anxiety around Europe’s reliance on the AstraZeneca plc (NASDAQ: AZN) vaccine and some hiccups in the reopening here at home.
Nasdaq Has Strong Overnight Session, Led By Tesla, As Yields Step Back
After a bumpy finish Friday, the road feels smoother as we start the final full week of Q1. This easy cruising might not last, however, with another appearance from Fed Chairman Jerome Powell on tap tomorrow. 
Fintech Focus For March 16, 2021
Quote To Start The Day: “When someone tells me something can’t be done, I think there’s always a will and a way.”
Barron's Latest Picks And Pans: COVID Booster Shot Plays, Defense M&As, Coty, Hologic, And More
This weekend's Barron's cover story offers a look at the 100 must sustainable companies. Other featured articles discuss the changing vaccine industry, the history of electric vehicles and consolidation in the defense sector.
'The Third Wave': Stock Market Update For The Week Ahead
The Past Week, In A Nutshell What Happened: In light of hopes for a sustained economic rebound, U.S. broad market indices pushed to new all-time highs.
World's Biggest Vaccine Producer Lends Support to AstraZeneca After Drugmaker Misstep
Serum Institute of India (SII), which has partnered with Novavax, Inc (NASDAQ: NVAX) and AstraZeneca Plc (NYSE: AZN) for trials in India, believes the latter’s COVID-19 vaccine is “a very good one.”
Benzinga's Bulls And Bears Of The Week: AstraZeneca, Disney, Ford, GE, Roku And More
AstraZeneca HQ and research center in Cambridge, United Kingdom Benzinga has examined the prospects for many investor favorite stocks over the past week.
Reinventing Vaccines To Save Lives And The Economy
Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) were the first to deliver good news regarding the efficiency of their coronavirus vaccine candidate.
Barron's Picks And Pans: Alibaba, Intel, Target, Visa And More
This weekend's Barron's cover offers a low-risk strategy for investors optimistic about an ecomomic recovery. Other featured articles discuss what a COVID-19 vaccine would mean for the stock market and how it could shake up the pharmaceutical industry.
Barron's Picks And Pans: AT&T, GE, Zynga And More
 
'Further Gains Ahead': Stock Market Update For The Week Ahead
The Past Week, In A Nutshell What Happened: Last week ended negative alongside mixed messaging on stimulus.
Fintech Focus For October 21, 2020
Bulls And Bears Of The Week: Chevron, Oracle, Twitter And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. Both bullish and bearish calls in coronavirus vaccine contenders were seen this week. Social media platforms were represented in both categories as well.
Current Updates On COVID-19 Vaccines
Besides saving lives and the global economy, we are expecting three things from the upcoming COVID-19 vaccine: safety, immunogenicity and efficacy. But we never had a 100 percent efficacy when it comes to respiratory viruses, so anything between 50 and 100% will be the best we've got as the WHO believes everything above 50 percent efficacy is acceptable.
'Room For Disappointment': Stock Market Update For The Week Ahead
The Past Week, In A Nutshell What Happened: Last week ended negative on relative weakness in the technology sector.
The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference
Biotech stocks continued to remain under pressure in the week ended Sept. 11, swayed by the volatility that was evident in the broader market.
AstraZeneca Resumes Coronavirus Vaccine Trials In U.K. After Independent Committee Approves of Safety
AstraZeneca plc (NYSE: AZN) can heave a sigh of relief following resumption of its coronavirus vaccine study that was voluntarily paused by the company.
Fintech Focus For September 10, 2020
Benzinga's Bulls And Bears Of The Week: Beyond Meat, Netflix, Johnson & Johnson And More
Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences
AstraZeneca Remains Committed To Development Of ZS-9 Despite Letter From FDA
Big Biotech In The Earnings Spotlight

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved